Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...
As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...
A major new study has highlighted significant health risks associated with popular weight loss injections such as Ozempic, ...
The new treatment targets gut hormone GLP-1 but also mimics amylin, a hormone released by the pancreas that suppresses hunger ...
Ozempic’s expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a ...
A woman who lost 64 pounds on a compounded form of the weight loss drug semaglutide, marketed as Wegovy and Ozempic, started ...
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...
The new drug, amycretin, similar to the company's blockbuster weight-loss and diabetes drugs Wegovy ... The company tested the once-weekly injection on 125 people for up to 36 weeks with ...